A drug with the SMILES CC(C)CC1Nc2ncnc(N3CCN(c4ccccc4)CC3)c2N(Cc2ccccc2)C1=O.O=C(O)C(F)(F)F has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 5.277\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(C)CC1Nc2ncnc(N3CCN(c4ccccc4)CC3)c2N(Cc2ccccc2)C1=O.O=C(O)C(F)(F)F
CC(C)CC1Nc2ncnc(N3CCN(c4ccccc4)CC3)c2N(Cc2ccccc2)C1=O.O=C(O)C(F)(F)F
5-benzyl-7-(2-methylpropyl)-4-(4-phenylpiperazin-1-yl)-7,8-dihydropteridin-6-one;2,2,2-trifluoroacetic acid